Syndax: Q1 Earnings Snapshot

Published: 2026-04-30 16:24:09 ET SNDX

Published on 04/30/2026 at 04:24 pm EDT

NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Thursday reported a loss of $42.7 million in its first quarter.

The New York-based company said it had a loss of 48 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The biopharmaceutical company posted revenue of $64.9 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $70 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News